Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer

Comprehensive characterization of the genomic landscape of epidermal growth factor receptor (EGFR)-mutated lung cancers have identified patterns of secondary mutations beyond the primary oncogenic EGFR mutation. These include concurrent pathogenic alterations affecting p53 (60–65%), RTKs (5–10%), PI...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Thorac Dis
Päätekijät: Gini, Beatrice, Thomas, Nicholas, Blakely, Collin M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2020
Aiheet:
Review Article on Mechanisms of Resistance to EGFR-targeted Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330397/
https://ncbi.nlm.nih.gov/pubmed/32642201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.03.78
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia